美农生物
(301156)
| 流通市值：13.57亿 | | | 总市值：25.59亿 |
| 流通股本：7462.48万 | | | 总股本：1.41亿 |
| 报告期 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 流动资产: | | | | |
| 货币资金 | 276,879,255.87 | 260,247,859.66 | 248,647,790.61 | 227,453,513.39 |
| 结算备付金 | 0 | 0 | 0 | 0 |
| 拆出资金 | 0 | 0 | 0 | 0 |
| 衍生金融资产 | 0 | 0 | 0 | 0 |
| 应收票据及应收账款 | 72,694,781.3 | 104,893,955.99 | 95,354,608.51 | 81,998,881.54 |
| 其中：应收票据 | 585,096 | 445,870.22 | 538,410 | 406,710 |
| 应收账款 | 72,109,685.3 | 104,448,085.77 | 94,816,198.51 | 81,592,171.54 |
| 应收款项融资 | 0 | 0 | 498,400 | 477,175 |
| 预付款项 | 13,937,484.71 | 9,675,328.48 | 4,540,314.18 | 9,475,178.82 |
| 应收保费 | 0 | 0 | 0 | 0 |
| 应收分保账款 | 0 | 0 | 0 | 0 |
| 应收分保合同准备金 | 0 | 0 | 0 | 0 |
| 其他应收款合计 | 612,832.73 | 221,922.08 | 216,288.23 | 286,190.81 |
| 其中:应收利息 | 0 | 0 | 0 | 0 |
| 应收股利 | 0 | 0 | 0 | 0 |
| 买入返售金融资产 | 0 | 0 | 0 | 0 |
| 存货 | 66,843,604.9 | 67,480,355.15 | 79,385,746.39 | 78,049,151.95 |
| 合同资产 | 0 | 0 | 0 | 0 |
| 一年内到期的非流动资产 | 0 | 0 | 0 | 0 |
| 其他流动资产 | 5,186,322.51 | 2,469,727.2 | 2,331,637.28 | 3,796,411.93 |
| 流动资产平衡项目 | 0 | 0 | 0 | 0 |
| 流动资产合计 | 456,625,049.91 | 485,472,169.16 | 512,278,106.91 | 496,713,347.54 |
| 非流动资产: | | | | |
| 发放委托贷款及垫款 | 0 | 0 | 0 | 0 |
| 债权投资 | 0 | 0 | 0 | 0 |
| 其他债权投资 | 0 | 0 | 0 | 0 |
| 长期应收款 | 0 | 0 | 0 | 0 |
| 长期股权投资 | 21,413,784.32 | 21,496,714.51 | 22,190,284.23 | 22,159,261.43 |
| 其他权益工具投资 | 0 | 0 | 0 | 0 |
| 其他非流动金融资产 | 2,747,174.38 | 2,805,818.48 | 2,465,028.46 | 2,232,452.6 |
| 投资性房地产 | 0 | 0 | 0 | 0 |
| 固定资产 | 197,017,434.4 | 202,043,475.39 | 199,314,358.22 | 204,603,619.48 |
| 在建工程 | 18,659,629.01 | 4,452,349.78 | 9,204,449.77 | 2,145,420.54 |
| 生产性生物资产 | 0 | 0 | 0 | 0 |
| 油气资产 | 0 | 0 | 0 | 0 |
| 使用权资产 | 425,768.33 | 644,852.24 | 863,936.15 | 1,083,020.06 |
| 无形资产 | 65,357,028.05 | 65,935,335.67 | 30,078,202.42 | 30,451,476.64 |
| 开发支出 | 0 | 0 | 0 | 0 |
| 商誉 | 0 | 0 | 0 | 0 |
| 长期待摊费用 | 3,561,959.63 | 3,125,427.22 | 2,435,290.04 | 2,568,076.35 |
| 递延所得税资产 | 2,168,589.99 | 3,175,051.11 | 2,451,712.11 | 2,332,734.38 |
| 其他非流动资产 | 697,175.84 | 1,118,510 | 638,245.48 | 3,132,283.01 |
| 非流动资产平衡项目 | 0 | 0 | 0 | 0 |
| 非流动资产合计 | 312,048,543.95 | 304,797,534.4 | 269,641,506.88 | 270,708,344.49 |
| 资产平衡项目 | 0 | 0 | 0 | 0 |
| 资产总计 | 768,673,593.86 | 790,269,703.56 | 781,919,613.79 | 767,421,692.03 |
| 流动负债: | | | | |
| 短期借款 | 0 | 0 | 0 | 0 |
| 向中央银行借款 | 0 | 0 | 0 | 0 |
| 吸收存款及同业存放 | 0 | 0 | 0 | 0 |
| 拆入资金 | 0 | 0 | 0 | 0 |
| 交易性金融负债 | 0 | 0 | 0 | 0 |
| 衍生金融负债 | 0 | 0 | 0 | 0 |
| 应付票据及应付账款 | 20,665,387.14 | 25,488,227.35 | 25,972,532.3 | 18,103,725.37 |
| 其中：应付票据 | 0 | 0 | 0 | 0 |
| 应付账款 | 20,665,387.14 | 25,488,227.35 | 25,972,532.3 | 18,103,725.37 |
| 预收款项 | 0 | 0 | 0 | 0 |
| 合同负债 | 1,964,015.54 | 299,682.74 | 1,037,542.11 | 922,815.44 |
| 卖出回购金融资产款 | 0 | 0 | 0 | 0 |
| 应付手续费及佣金 | 0 | 0 | 0 | 0 |
| 应付职工薪酬 | 5,959,508.47 | 13,296,959.4 | 10,078,230.84 | 7,673,551.72 |
| 应交税费 | 679,671.89 | 2,000,810.86 | 1,378,627.62 | 531,835.5 |
| 其他应付款合计 | 816,775.72 | 1,077,235 | 885,096.87 | 695,833.51 |
| 其中:应付利息 | 0 | 0 | 0 | 0 |
| 应付股利 | 0 | 0 | 0 | 0 |
| 应付分保账款 | 0 | 0 | 0 | 0 |
| 保险合同准备金 | 0 | 0 | 0 | 0 |
| 代理买卖证券款 | 0 | 0 | 0 | 0 |
| 代理承销证券款 | 0 | 0 | 0 | 0 |
| 一年内到期的非流动负债 | 73,229.09 | 72,441.3 | 574,931.85 | 488,694.27 |
| 其他流动负债 | 105,618.04 | 410,217.11 | 385,695.8 | 365,394.31 |
| 流动负债平衡项目 | 0 | 0 | 0 | 0 |
| 流动负债合计 | 30,264,205.89 | 42,645,573.76 | 40,312,657.39 | 28,781,850.12 |
| 非流动负债: | | | | |
| 长期借款 | 0 | 0 | 0 | 0 |
| 应付债券 | 0 | 0 | 0 | 0 |
| 优先股 | 0 | 0 | 0 | 0 |
| 永续债 | 0 | 0 | 0 | 0 |
| 租赁负债 | 156,314.78 | 154,633.14 | 152,969.6 | 232,040.16 |
| 长期应付款 | 0 | 0 | 0 | 0 |
| 长期应付职工薪酬 | 0 | 0 | 0 | 0 |
| 预计负债 | 0 | 0 | 0 | 0 |
| 递延收益 | 2,532,199.07 | 2,620,856.72 | 1,401,653.27 | 1,454,007.17 |
| 递延所得税负债 | 0 | 0 | 0 | 0 |
| 其他非流动负债 | 0 | 0 | 0 | 0 |
| 非流动负债平衡项目 | 0 | 0 | 0 | 0 |
| 非流动负债合计 | 2,688,513.85 | 2,775,489.86 | 1,554,622.87 | 1,686,047.33 |
| 负债平衡项目 | 0 | 0 | 0 | 0 |
| 负债合计 | 32,952,719.74 | 45,421,063.62 | 41,867,280.26 | 30,467,897.45 |
| 所有者权益(或股东权益): | | | | |
| 实收资本(或股本) | 140,784,675 | 145,191,440 | 145,191,440 | 145,191,440 |
| 其他权益工具 | 0 | 0 | 0 | 0 |
| 优先股 | 0 | 0 | 0 | 0 |
| 永续债 | 0 | 0 | 0 | 0 |
| 资本公积 | 308,240,668.61 | 364,842,298.42 | 364,833,186.66 | 364,833,186.66 |
| 减:库存股 | 0 | 42,997,275.56 | 29,813,559.97 | 21,292,185.85 |
| 其他综合收益 | 0 | 0 | 0 | 0 |
| 专项储备 | 0 | 0 | 0 | 0 |
| 盈余公积 | 43,746,279.97 | 43,746,279.97 | 39,184,573.11 | 39,184,573.11 |
| 一般风险准备 | 0 | 0 | 0 | 0 |
| 未分配利润 | 242,949,250.54 | 234,065,897.11 | 220,656,693.73 | 209,036,780.66 |
| 归属于母公司股东权益平衡项目 | 0 | 0 | 0 | 0 |
| 归属于母公司股东权益合计 | 735,720,874.12 | 744,848,639.94 | 740,052,333.53 | 736,953,794.58 |
| 少数股东权益 | 0 | 0 | 0 | 0 |
| 股东权益平衡项目 | 0 | 0 | 0 | 0 |
| 股东权益合计 | 735,720,874.12 | 744,848,639.94 | 740,052,333.53 | 736,953,794.58 |
| 负债和股东权益合计 | 768,673,593.86 | 790,269,703.56 | 781,919,613.79 | 767,421,692.03 |
| 公告日期 | 2025-04-26 | 2025-04-26 | 2024-10-30 | 2024-08-28 |
| 审计意见(境内) | | 标准无保留意见 | | |